Venture Certified
| 기술평가보증기업(기금) | 2021-01-21 ~ 2023-01-20 | 20210100557 | 2021-01-21 |
| 혁신성장유형 | 2023-01-21 ~ 2026-01-20 | 20221228030068 | 2021-01-21 |
| 혁신성장유형 | 2026-01-21 ~ 2029-01-20 | 20260113030029 | 2021-01-21 |
Revenue CAGR +38.0%
| Item | 2024 | 2023 | 2022 |
|---|---|---|---|
| Revenue | 36B | 23B | 19B |
| Operating Profit | 14B | 3.9B | 6.1B |
| Net Profit | 17B | 5.4B | 7.9B |
| Total Assets | 40B | 21B | 16B |
| Total Liabilities | 7.4B | 2.4B | 1.9B |
| Total Equity | 32B | 18B | 14B |
Debt Ratio Surge (+10pp YoY)
▲ 70.3%
▲ 181.5%
▲ 59.8%
▲ 71.9%
▲ 18.9%
| Name | Position | Role |
|---|---|---|
| 김송희 | 대표이사 | 대표 |
No Data – Contact
No procurement record or data not yet available| Tax Type | 부가가치세 일반과세자 |
| Status | Cert. flags confirmed (details update after further collection) |
1 Additional Data Sources
{
"address": "광주광역시 북구",
"ceo_name": "김송희",
"certificate": [
{
"cert_number": "20210100557",
"changes": "",
"disclosure_date": "2021-01-21",
"first_cert_date": "2021-01-21",
"no": "1",
"type": "기술평가보증기업(기금)",
"valid_period": "2021-01-21 ~ 2023-01-20"
},
{
"cert_number": "20221228030068",
"changes": "",
"disclosure_date": "2022-12-28",
"first_cert_date": "2021-01-21",
"no": "2",
"type": "혁신성장유형",
"valid_period": "2023-01-21 ~ 2026-01-20"
},
{
"cert_number": "20260113030029",
"changes": "",
"disclosure_date": "2026-01-13",
"first_cert_date": "2021-01-21",
"no": "3",
"type": "혁신성장유형",
"valid_period": "2026-01-21 ~ 2029-01-20"
}
],
"company_name": "(주)킴즈메드",
"corp_no": "200111-*******",
"financials": {
"2022": {
"capital_stock": 110000000,
"cost_of_sales": 826998000,
"current_assets": 1529575000,
"current_liabilities": 188932000,
"gross_profit": 1061708000,
"net_income": 794627000,
"net_income_bs": 715779000,
"non_current_assets": 37817000,
"non_current_liabilities": 0,
"non_operating_expenses": 8540000,
"non_operating_income": 194570000,
"operating_profit": 608597000,
"revenue": 1888705000,
"sga_expenses": 453110000,
"total_assets": 1567393000,
"total_equity": 1378461000,
"total_liabilities": 188932000
},
"2023": {
"capital_stock": 110000000,
"cost_of_sales": 965174000,
"current_assets": 1591808000,
"current_liabilities": 235146000,
"gross_profit": 1372336000,
"net_income": 543919000,
"net_income_bs": 497277000,
"non_current_assets": 489076000,
"non_current_liabilities": 0,
"non_operating_expenses": 20436000,
"non_operating_income": 170192000,
"operating_profit": 394163000,
"revenue": 2337510000,
"sga_expenses": 978173000,
"total_assets": 2080884000,
"total_equity": 1845738000,
"total_liabilities": 235146000
},
"2024": {
"capital_stock": 110000000,
"cost_of_sales": 1402775000,
"current_assets": 3524539000,
"current_liabilities": 738555000,
"gross_profit": 2196137000,
"net_income": 1683581000,
"net_income_bs": 1453919000,
"non_current_assets": 463672000,
"non_current_liabilities": 0,
"non_operating_expenses": 34762000,
"non_operating_income": 306987000,
"operating_profit": 1411356000,
"revenue": 3598913000,
"sga_expenses": 784782000,
"total_assets": 3988212000,
"total_equity": 3249657000,
"total_liabilities": 738555000
}
},
"industry": "그 외 기타 의료용 기기 제조업",
"investment": [],
"main_products": "이식용의료기기삽입용 보조기구",
"phone": "070-5208-****",
"years": [
2024,
2023,
2022
]
}Data Quality: 8/10 | Primary Source: Venture System | Section Coverage: 7/8
| Section | Source: | Status |
|---|---|---|
| Basic Info | Public Data | Collected |
| Financial Statements | Venture System | Collected |
| Investment Metrics | Venture System | Collected |
| Officers | Public Data | Collected |
| Employment | Not Collected | Not Collected |
| Certifications | Public Data | Collected |
| Patents | KIPRIS | Collected |
| Procurement | G2B Procurement | Collected |
| API | Collected | Status |
|---|---|---|
| G2B Procurement | 2026-02-25 | Collected |
| Employment Insurance | 2026-02-25 | Collected |
| KIPRIS Patents | 2026-02-25 | Collected |
| HomeTax Business | 2026-02-25 | Collected |
| Venture System Detail | 2026-02-25 | Collected |